Protagonist Therapeutics, Inc
PTGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001377121
In the last 90 days, Protagonist Therapeutics, Inc insiders filed 0 open-market purchases and 2 sales; 346 institutions reported holding it in 13F filings for Q2 2026, worth $9.30B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Protagonist Therapeutics, Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 133
- +2 vs. Q2 2022
- Shares held
- 47.3M
- −6.02M (−11.3%) vs. Q2 2022
- Total value
- $398.9M
- −$23.2M (−5.5%) vs. Q2 2022
- New holders
- 28
- 41 more added
- Sold out
- 26
- 41 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PTGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 346 | $9.30B |
| Q1 2026 | 322 | $8.31B |
| Q4 2025 | 319 | $6.18B |
| Q3 2025 | 275 | $4.70B |
| Q2 2025 | 274 | $3.92B |
| Q1 2025 | 275 | $3.15B |
| Q4 2024 | 241 | $2.44B |
| Q3 2024 | 240 | $2.78B |
| Q2 2024 | 188 | $2.05B |
| Q1 2024 | 185 | $1.73B |
| Q4 2023 | 157 | $1.32B |
| Q3 2023 | 144 | $945.9M |
| Q2 2023 | 167 | $1.57B |
| Q1 2023 | 138 | $1.22B |
| Q4 2022 | 137 | $533.3M |
| Q3 2022 | 133 | $398.9M |
| Q2 2022 | 131 | $422.1M |
| Q1 2022 | 140 | $1.19B |
| Q4 2021 | 149 | $1.68B |
| Q3 2021 | 132 | $820.8M |
| Q2 2021 | 139 | $2.16B |
| Q1 2021 | 127 | $1.15B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Protagonist Therapeutics, Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | 230,847 | $1.94M | 0.00% | −58,715−20.3% | Reduced |
| UBS Oconnor LLC | 232,820 | $1.96M | 0.02% | +13,000+5.9% | Added |
| BNP Paribas Arbitrage, SA | 236,263 | $1.99M | 0.01% | +192,626+441.4% | Added |
| Silvercrest Asset Management Group LLC | 243,013 | $2.05M | 0.02% | +128,254+111.8% | Added |
| Two Sigma Investments, LP | 245,705 | $2.07M | 0.01% | −69,939−22.2% | Reduced |
| Jacobs Levy Equity Management, Inc | 254,340 | $2.14M | 0.02% | +254,340 | New |
| Bank of America Corp | 310,049 | $2.61M | 0.00% | +2,819+0.9% | Added |
| Citigroup Inc | 315,194 | $2.66M | 0.00% | −2,305−0.7% | Reduced |
| Charles Schwab Investment Management Inc | 333,643 | $2.81M | 0.00% | +8,885+2.7% | Added |
| Nuveen Asset Management, LLC | 338,544 | $2.85M | 0.00% | +572+0.2% | Added |
| Rafferty Asset Management, LLC | 346,935 | $2.92M | 0.03% | +32,703+10.4% | Added |
| Renaissance Technologies LLC | 399,767 | $3.37M | 0.00% | +76,900+23.8% | Added |
| Two Sigma Advisers, LP | 407,300 | $3.43M | 0.01% | −111,100−21.4% | Reduced |
| Northern Trust Corp | 417,783 | $3.52M | 0.00% | −5,671−1.3% | Reduced |
| Voloridge Investment Management, LLC | 426,393 | $3.59M | 0.02% | −170,094−28.5% | Reduced |
| Kynam Capital Management, LP | 519,212 | $4.38M | 0.92% | +519,212 | New |
| Goldman Sachs Group Inc | 757,079 | $6.38M | 0.00% | +125,163+19.8% | Added |
| Deutsche Bank AG | 812,355 | $6.85M | 0.00% | −5,477−0.7% | Reduced |
| Marshall Wace, LLP | 814,726 | $6.87M | 0.02% | +350,669+75.6% | Added |
| Dimensional Fund Advisors LP | 820,438 | $6.92M | 0.00% | −32,337−3.8% | Reduced |
| Geode Capital Management, LLC | 827,456 | $6.97M | 0.00% | +5,535+0.7% | Added |
| Citadel Advisors LLC | 866,387 | $7.30M | 0.01% | +792,258+1,068.8% | Added |
| Adage Capital Partners GP, L.L.C. | 873,045 | $7.36M | 0.02% | −127,000−12.7% | Reduced |
| Morgan Stanley | 2,227,575 | $18.8M | 0.00% | +451,123+25.4% | Added |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19.1M | 2.27% | 00.0% | Unchanged |
| Johnson & Johnson | 2,449,183 | $20.6M | 6.08% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 2,537,993 | $21.4M | 0.09% | −1,518,207−37.4% | Reduced |
| FMR LLC | 2,808,808 | $23.7M | 0.00% | −682,198−19.5% | Reduced |
| Vanguard Group Inc | 2,942,767 | $24.8M | 0.00% | +208,002+7.6% | Added |
| BlackRock Inc. | 3,462,384 | $29.2M | 0.00% | +7,468+0.2% | Added |
| Farallon Capital Management, L.L.C. | 3,651,887 | $30.8M | 0.19% | −48,721−1.3% | Reduced |
| RTW Investments, LP | 4,176,837 | $35.2M | 0.81% | −617,662−12.9% | Reduced |
| State Street Corp | 4,676,682 | $39.4M | 0.00% | −2,099,587−31.0% | Reduced |
| BVF Inc | 0 | $0 | 0.00% | −1,106,838−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −1,065,724−100.0% | Sold out |
| Finepoint Capital LP | 0 | $0 | 0.00% | −735,126−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −388,637−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −320,426−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −164,075−100.0% | Sold out |
| Capital Fund Management S.A. | 0 | $0 | 0.00% | −116,807−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −61,370−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −57,923−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −55,800−100.0% | Sold out |
| Amitell Capital Pte Ltd | 0 | $0 | 0.00% | −50,129−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −46,459−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −20,317−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −16,499−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −14,328−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,540−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −11,845−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −11,640−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,383−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −11,170−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −10,836−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −10,338−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −128−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −28−100.0% | Sold out |